Navigation Links
Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Date:9/16/2013

1.1 Overview 183.1.2 Efficacy Profile 193.1.3 Safety Profile 193.2 Qsymia, Vivus, Inc. 193.2.1 Overview 193.2.2 Efficacy Profile 203.2.3 Safety Profile 213.2.4 Discussion 223.3 Orlistat 223.3.1 Overview 223.3.2 Efficacy Profile 233.3.3 Safety Profile 253.3.4 Discussion 253.4 Belviq, Arena Pharmaceuticals 263.4.1 Introduction 263.4.2 Efficacy Profile 263.4.3 Safety Profile 273.4.4 Discussion 273.5 Low Long-term Success Rate of Marketed Anti-Obesity Drugs 283.6 Discussion 294 Pipeline 334.1 Overview of Pipeline by Phase, Molecule Type and Molecular Target 334.2 Clinical Trial Duration and Size 364.2.1 Clinical Trial Duration 364.2.2 Clinical Trial Size 384.3 Clinical Trial Failure, Attrition Rate and Reasons for Clinical Trial Failure 394.4 Primary and Secondary Endpoints 414.5 Late-stage Drugs of the Developmental Pipeline 434.5.1 Contrave, Orexigen Therapeutics 434.5.2 Cametor, Norgine BV 454.5.3 Victoza, Novo Nordisk 474.5.4 Tesofensine (NeuroSearch) 504.6 Discussion 515 Market Forecasts 545.1 Global Market 545.2 The US 565.2.1 Epidemiology and Treatment Usage Patterns 565.2.2 Annual Cost of Therapy 565.2.3 Market Size 565.3 Europe 585.3.1 Treatment Usage Patterns 585.3.2 Annual Cost of Therapy 605.3.3 Market Size 615.4 Japan 635.4.1 Treatment Usage Patterns 635.4.2 Annual Cost of Therapy 635.4.3 Market Forecast 635.5 Discussion 645.6 Drivers and Barriers of the Anti-obesity Market 655.7 Obesity Market Drivers 655.7.1 Obesity is a Very Prevalent Disease with Large Potential Target Populations Globally 655.7.2 Recent Approval of Qsymia to Drive Market Growth Providing its Long-term Safety is Proved 655.7.3 Diversification of Molecular Targets 655.8 Obesity Market Barriers 665.8.1 Low Treatment Rate 665.8.2 Reimbursement Issues 666 Licensing and Co-Development Deals 676.1 Licensing Deals 676.1.1 EMD Serono Enters into Collaboration and Licensing Agreement with Theratechnologies 686.1.2 Amylin Pharma Enters into Lice
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Childhood Obesity Need Not Last a Lifetime, says Beverly Hills Physicians
2. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
3. seca Supports Obesity Therapy with the New medical Body Composition Analyzer
4. Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
5. The Financial Impact of Obesity in Brazil and Mexicos Healthcare Systems is Driving Partial Coverage of Obesity Drugs in Formularies at the State, Municipal and Hospital Levels
6. NGM Biopharmaceuticals Secures $50 Million in Series C Financing to Advance its Portfolio of Novel Therapies for Diabetes and Obesity
7. Link Between Cancer and Obesity Argues for More Aggressive Treatments, says Dr. Feiz & Associates
8. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
9. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
10. Analysis In Health Economics Review Concludes Effective Medical Obesity Treatment Could Reduce Medicare Spending
11. Americas Interest in Obesity Surgery Soars Following its Success in Europe and ROW, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Uroplasty, Inc. (NASDAQ: UPI ), a ... innovative proprietary products to treat voiding dysfunctions, today ... quarter ended June 30, 2014.  Global revenue ... grew 19% to $4.1 million, as compared to ... prior year.  Total revenue for the fiscal first ...
(Date:7/24/2014)... , July 24, 2014  IRIDEX Corporation (NASDAQ: ... release its second quarter 2014 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, July ... quarter and other business developments. Interested parties ...
(Date:7/24/2014)... IGI Laboratories, Inc. (NYSE MKT: IG), a ... pharmaceutical company, today announced it has accepted  Damian ... Finio has accepted a senior level finance position at ... acceptance of his new position, Mr. Finio will be ... IGI Laboratories, Inc.  The effective date of his resignation ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... 21 Accuray Incorporated (Nasdaq: ARAY ), a ... plans to establish an America,s region thereby establishing regionalized ... , The formation of this new Americas region, ... and Japan, gives each region control of revenue and ...
... , WARSAW, Ind., Oct. 21 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending October 3, 2009 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Accuray Announces Regionalized Management Strategy for Americas 2Accuray Announces Regionalized Management Strategy for Americas 3Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2
(Date:7/25/2014)... The Little Gym of Houston will ... July 27 at Discovery Green in downtown Houston. The ... Pearland, Friendswood, Spring, The Woodlands, Sugarland-Missouri City, Kingwood, Bellaire ... “We’re thrilled to be attending and performing at the ... owns the Sugarland-Missouri City location. “We believe in the ...
(Date:7/25/2014)... July 25, 2014 AttorneyOne.com, a recognized authority ... information from the FDA on Ibuprofen and Oxcarbazepine Tablets ... one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, ... to mislabeled packaging. Oxcarbazepine is used for the treatment of ... , The reason for the recall is that Lot #142588, ...
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
(Date:7/25/2014)... July 25, 2014 On July ... Nuanced Media client and the nation’s number one ... employee handbooks, announced their partnership with TransAct Merchant ... a registered ISO/MSP of Chase Paymentech Solutions, LLC, ... processing industry. Companies that are members of TransAct’s ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Hastings and ... offering discount attorney’s fees with regard to personal injury ... provide a wide range of legal services for those ... negligence of another individual or corporation. Free initial consultation ... the validity of a potential personal injury claim ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3
... Enables Users to Upload Video Confessions/ Testimonials for ... for Peer-to-Peer Viewing, PHILADELPHIA and LONDON, Nov. ... (NYSE: TOC ; TSX: TOC) and,leading provider ... communities, today announced the launch of its new ...
... (Nasdaq: SPPI ) announced today that it will ... 2007, at 2:00 p.m.,Pacific, at the BIOCOM Investor Conference, ... California. Spectrum,s presentation will be held in Room,3 of ... of Spectrum,s presentation will be available at, http://www.spectrumpharm.com . ...
... MISSISSAUGA, ON, Oct. 31 /PRNewswire-FirstCall/ - DRAXIS Health Inc.,(TSX: ... Barkin today informed,the board of directors that he will ... Company effective December 31, 2007. Dr. Barkin joined ... fifteen years, he has been instrumental in guiding the ...
... Human Services Agency Secretary Kim Belshe indicated in,legislative ... Governor,s,plan to require all Californians to buy private ... digit insurance company premium increases.,The proposal does not ... and Consumer Rights., In response to questions ...
... Fla., Oct. 31 Cogon Systems, Inc. has ... by the U.S.,Army,s Telemedicine & Advanced Technology Research ... for hand held computer,use. The primary goal ... mobile,technology in an inpatient setting to deliver clinical ...
... Calif., Oct. 31 Always Best Care Senior,Services ... In-Home Care, Assisted Living Placement Service, and Personal,Response ... can now,rely on Always Best Care Senior Services ... relationship has been the foundation of our work ...
Cached Medicine News:Health News:Thomson Scientific Launches 'Confessions ... of a User' Campaign Asking 'Are You the New Face of Research?' 2Health News:Spectrum Pharmaceuticals to Present at the 2007 BIOCOM Investor Conference 2Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 2Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 3Health News:DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer 4Health News:Governor's Health Plan Hides the True Cost of a Mandatory Purchase Requirement, Testimony Shows 2Health News:U.S. Army Selects Cogon Systems to Develop Advanced Clinical Decision Support Tools for Hand Held Computers 2Health News:Announcing Always Best Care Senior Services Expansion Into the Littleton/Denver, Colorado Area 2
Bones is a remarkable guide for the Medical Student, Nurse, Nurse Practitioner, Physician's Assistant or Physician to Bones....
The Urinary System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the urinary system....
... The perfect on-the-spot ... symptoms and disease. On ... office, on rounds, or ... reference provides instant access ...
The Nervous System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the nervous system....
Medicine Products: